TACROLIMUS
| Brand name | PROGRAF |
|---|---|
| Active ingredient | TACROLIMUS |
| Strength | EQ 0.2MG BASE/PACKET |
| Dosage form | FOR SUSPENSION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | May 2018 |
| Marketing status | RX |
| Code | Expires |
|---|---|
| ODE-360 | July 2028 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.